J Virol. 1985 December; 56(3): 757-766
Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells.
S R Jennings,
P L Rice,
E D Kloszewski,
R W Anderson,
D L Thompson and
S S Tevethia
ABSTRACT
Cytotoxic T lymphocytes (CTL) generated in C57BL/6 (H-2b) mice in response to infection with the serologically distinct herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) were cross-reactive against target cells infected with either serotype. However, HSV-2-infected cells were shown to be much less susceptible to CTL-mediated lysis, and analysis through the use of HSV-1 X HSV-2 intertypic recombinants mapped the reduced susceptibility to a region contained within 0.82 to 1.00 map units of the HSV-2 genome. The study reported here was undertaken to determine the possible reasons for the reduced susceptibility of HSV-2-infected cells to lysis by CTL. Competition for the specific lysis of labeled HSV-1-infected cells by either HSV-1- or HSV-2-infected, unlabeled inhibitor cells and frequency analysis of the CTL precursor able to recognize HSV-1- and HSV-2-infected cells suggested that the reduced susceptibility of HSV-2-infected cells to lysis could be explained, at least in part, by reduced levels of target cell recognition. A determination of the surface expression of the critical elements involved in target cell recognition by CTL following infection with HSV-1 or HSV-2 revealed that all the major HSV-specific glycoprotein species were expressed. Infection with both HSV-1 and HSV-2 caused a reduction in the expression of the class I H-2 antigens. However, this reduction was much greater following infection with HSV-2. This suggested that one important factor contributing to reduced lysis of HSV-2-infected cells may be the altered or reduced expression of the class I H-2 self-antigens.
J Virol. 1985 December; 56(3): 757-766
This article has been cited by other articles:
-
Simpson, G. R., Han, Z., Liu, B., Wang, Y., Campbell, G., Coffin, R. S.
(2006). Combination of a Fusogenic Glycoprotein, Prodrug Activation, and Oncolytic Herpes Simplex Virus for Enhanced Local Tumor Control.. Cancer Res.
66: 4835-4842
[Abstract]
[Full Text]
-
Carr, D. J. J., Noisakran, S.
(2002). The Antiviral Efficacy of the Murine Alpha-1 Interferon Transgene against Ocular Herpes Simplex Virus Type 1 Requires the Presence of CD4+, {alpha}/{beta} T-Cell Receptor-Positive T Lymphocytes with the Capacity To Produce Gamma Interferon. J. Virol.
76: 9398-9406
[Abstract]
[Full Text]
-
Harle, P., Cull, V., Agbaga, M.-P., Silverman, R., Williams, B. R. G., James, C., Carr, D. J. J.
(2002). Differential Effect of Murine Alpha/Beta Interferon Transgenes on Antagonization of Herpes Simplex Virus Type 1 Replication. J. Virol.
76: 6558-6567
[Abstract]
[Full Text]
-
Haque, M., Ueda, K., Nakano, K., Hirata, Y., Parravicini, C., Corbellino, M., Yamanishi, K.
(2001). Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. J. Gen. Virol.
82: 1175-1180
[Abstract]
[Full Text]
-
Alvarez-Barrientos, A., Arroyo, J., Canton, R., Nombela, C., Sanchez-Perez, M.
(2000). Applications of Flow Cytometry to Clinical Microbiology. Clin. Microbiol. Rev.
13: 167-195
[Abstract]
[Full Text]
-
Everly, D. N. Jr., Read, G. S.
(1999). Site-Directed Mutagenesis of the Virion Host Shutoff Gene (UL41) of Herpes Simplex Virus (HSV): Analysis of Functional Differences between HSV Type 1 (HSV-1) and HSV-2 Alleles. J. Virol.
73: 9117-9129
[Abstract]
[Full Text]
-
Sparks-Thissen, R. L., Enquist, L. W.
(1999). Differential Regulation of Dk and Kk Major Histocompatibility Complex Class I Proteins on the Cell Surface after Infection of Murine Cells by Pseudorabies Virus. J. Virol.
73: 5748-5756
[Abstract]
[Full Text]
-
Jerome, K. R., Tait, J. F., Koelle, D. M., Corey, L.
(1998). Herpes Simplex Virus Type 1 Renders Infected Cells Resistant to Cytotoxic T-Lymphocyte-Induced Apoptosis. J. Virol.
72: 436-441
[Abstract]
[Full Text]
-
Todo, T., Martuza, R. L., Rabkin, S. D., Johnson, P. A.
(2001). Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing. Proc. Natl. Acad. Sci. USA
98: 6396-6401
[Abstract]
[Full Text]
Copyright © 1985 by the American Society for Microbiology. All rights reserved.